BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/21/2023 6:10:46 AM | Browse: 488 | Download: 1633
 |
Received |
|
2022-11-06 05:15 |
|
Peer-Review Started |
|
2022-11-06 05:17 |
|
First Decision by Editorial Office Director |
|
2023-01-03 10:33 |
|
Return for Revision |
|
2023-01-03 10:33 |
|
Revised |
|
2023-01-27 11:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-03-03 03:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-03-03 09:05 |
|
Articles in Press |
|
2023-03-03 09:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-08 10:09 |
|
Publish the Manuscript Online |
|
2023-03-21 06:10 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Retrospective Study |
| Article Title |
Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Preeti Vani, Malte Neuss, Nitish Garg, Raman Chawla, Vivek Tandon, Deepak Garg and Nilesh Parshottam |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Preeti Vani, MSc, Researcher, Medical Division, Sahjanand Laser Technology Limited, A-8,G.I.D.C, Electronic Estate, Sec-25, Gandhinagar-382016, Gujarat, India., Gandhinagar 382016, India. preeti.vani@sltl.in |
| Key Words |
Coronary artery disease; Drug-eluting stents; Percutaneous coronary intervention; Rapamycin; Sirolimus |
| Core Tip |
Biodegradable polymer drug-eluting stents (BP-DES) have been proven to minimize restenosis and stent thrombosis. Our study evaluates the safety and effectiveness of FlexyRap® DES at the 5-year clinical response in real-world settings. The study proved the feasibility, safety, and efficacy of the FlexyRap® rapamycin-eluting stent for the treatment of de novo coronary artery disease, indicating low rates of events and stent thrombosis at 5-year follow-up. |
| Publish Date |
2023-03-21 06:10 |
| Citation |
Garg N, Chawla R, Tandon V, Garg D, Parshottam N, Vani P, Neuss M. Real-world five-year outcomes of FlexyRap® cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease. World J Cardiol 2023; 15(3): 84-94
|
| URL |
https://www.wjgnet.com/1949-8462/full/v15/i3/84.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v15.i3.84 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
